NovoSeven® RT is 93% effective at stopping nonsurgical and surgical bleeds in people with congenital FVII deficiency.a
Living with congenital factor VII deficiency?
NovoSeven® RT has the proven effectiveness you expect from your treatment.

Living with congenital factor VII deficiency?
NovoSeven® RT has the proven effectiveness you expect from your treatment.

Shown to be effective in stopping nonsurgical and surgical bleeds.
aFrom an analysis of published cases and people who took part in trials and registries.


Portability that fits an active lifestyle.
NovoSeven® RT is room temperature stable up to 77°F, so you can be on the go. And, with compact packaging, you can take it along where you need to go.
For complete storage information, please see Prescribing Information.
Quick to mix.b
NovoSeven® RT with MixPro® makes mixing a dose as easy as attach, twist, and mix. The prefilled syringe saves time—there are no extra steps to fill a syringe with diluent.

After mixing, NovoSeven® RT may be stored at room temperature in the vial for up to 3 hours.
bCompared with mixing using histidine vials.
Fast to infuse.
NovoSeven® RT requires a low infusion volume, so infusing takes 2 to 5 minutes.

Established safety profile.

What if I need surgery or a procedure?
We understand that you have concerns about controlling bleeds if you ever need surgery or a procedure. The good news is that NovoSeven® RT prevents bleeds during and after surgery and procedures in people with congenital FVII deficiency.
Talk to your doctor for more information on the surgical use of NovoSeven® RT.
What about surgery and procedures?
Approved for surgical use and procedures for patients with congenital FVII deficiency.

Hear from people who
share your experience.

New to treatment? It's
easy to get started.
